- STAT+: A suspicious denial pattern in Medicare AdvantageMajor Medicare Advantage plans almost always reversed their denials on appeal, raising big questions about barriers to care.STAT · 1mo ago↗ source
- STAT+: Novartis doubles down on molecular glue strategySeniors' drug costs rise sharply, Enliven's leukemia drugs, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- STAT+: Pharmalittle: We’re reading about employer coverage of obesity drugs, another Sanofi setback, and moreMore employers are planning to drop coverage of GLP-1 drugs for weight loss next year as increasing numbers of people take the medicationsSTAT · 1mo ago↗ source